Skip to content

Phentolamine

Published: July 26, 2026Updated: July 26, 2026

Phentolamine mesylate is an alpha-adrenergic blocking agent used primarily in dentistry to reverse soft-tissue anesthesia and reduce associated functional deficits such as lip and cheek numbness following dental procedures. It works by blocking alpha-adrenergic receptors, causing vasodilation and increased blood flow to the affected area.

Quick summary

Phentolamine is a short-acting alpha-blocker used to reverse local anesthesia in dental patients.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
C04AB01
RxNorm
8153
Generic
Phentolamine
Class
atc-c04
Brands
Ryzumvi, OraVerse
Availability
rx
Pregnancy
C
Lactation
caution
Routes
ophthalmic
Forms
solution, injection
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose significantly exceeding therapeutic range (typically 1-5mg) that may cause serious cardiovascular toxicity including severe hypotension and tachycardia
Chronic overdose: Repeated administrations exceeding recommended dosing intervals may lead to cumulative cardiovascular effects including persistent hypotension and cardiac arrhythmias
Immediate actions
Establish IV access, place patient in Trendelenburg position, administer intravenous fluids, continuous cardiac monitoring, gastric decontamination if ingestion is recent
Antidote
No specific antidote exists; treatment is supportive and symptomatic(N/A - supportive care is the primary treatment approach; early intervention improves outcomes)
Poison Control: 1-800-222-1222

Special Populations

10 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use only if potential benefits justify potential risk to fetus; consider alternative therapies

Monitor

regular fetal monitoring and ultrasound assessments

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

use lowest effective dose

Key Recommendations

use only when absolutely necessary for maternal indication; weigh risks and benefits carefully

Monitor

fetal heart rate monitoring and growth assessments

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

use lowest effective dose

Key Recommendations

discontinue if possible before delivery; use only for severe hypertension

Monitor

close fetal monitoring and uterine activity assessment

Use with caution and monitor for adverse effects.

?

lactation

breastfeeding
unknown
FDA Category
N
Dose Adjustment

use with caution

Key Recommendations

discontinue breastfeeding or pump and discard milk during treatment and for 24 hours after administration

Monitor

observe infant for adverse effects

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

start with lower dose and titrate slowly

Key Recommendations

use reduced initial dose; monitor blood pressure closely for orthostatic hypotension

Monitor

regular blood pressure monitoring, renal function assessment

Use with caution and monitor for adverse effects.

⚠

pediatric_age

children 2 12 years
caution
FDA Category
N
Dose Adjustment

weight-based dosing; reduce dose

Key Recommendations

use only for specific indications; pediatric use based on limited clinical data

Monitor

close blood pressure and heart rate monitoring

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

may require dose reduction

Key Recommendations

use with caution; monitor renal function and blood pressure

Monitor

monitor renal function, serum electrolytes, blood pressure

Use with caution and monitor for adverse effects.

⚠

renal_impairment

severe
caution
FDA Category
N
Dose Adjustment

significant dose reduction recommended

Key Recommendations

use with extreme caution; consider alternative therapies if available

Monitor

frequent renal function monitoring, blood pressure checks, ECG monitoring

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
N
Dose Adjustment

may require dose reduction

Key Recommendations

use with caution; monitor liver function tests

Monitor

liver function tests, blood pressure monitoring

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

severe
caution
FDA Category
N
Dose Adjustment

significant dose reduction required

Key Recommendations

use only if absolutely necessary; consider alternative therapies

Monitor

frequent liver function monitoring, blood pressure and heart rate monitoring

Use with caution and monitor for adverse effects.

Statistics and clinical data

drug_classWHO
2023

Drug class

Value:Alpha-adrenergic antagonist

Non-selective alpha-1 and alpha-2 adrenergic receptor blocker

mechanismFDA
2023

Mechanism of action

Value:Competitive alpha-adrenergic blockade

Blocks alpha-1 and alpha-2 receptors causing vasodilation

usageMedical guidelines
2023

Common uses

Value:Dental anesthesia reversal, hypertensive emergencies, pheochromocytoma management

Therapeutic applications

prescribingFDA
2023

FDA approval OraVerse

Value:2008

Dental anesthetic reversal agent approval

Reversal of soft-tissue anesthesia and functional deficits (lip numbness, cheek numbness) following dental procedures using local anesthetics with vasoconstrictors. May also be used off-label for hypertensive emergencies and pheochromocytoma management.

Phentolamine mesylate competitively blocks alpha-adrenergic receptors (both alpha-1 and alpha-2), preventing catecholamine binding and resulting in smooth muscle relaxation, vasodilation, and increased peripheral blood flow. This action reverses the vasoconstrictive effects of local anesthetics and accelerates restoration of normal sensation.

Short duration of action limits systemic effects. Contraindicated in patients with hypersensitivity to phentolamine or related compounds. Use cautiously in patients with cardiovascular disease, as it may cause hypotension or tachycardia. Safety in pregnancy and nursing has not been established. Onset is rapid when administered locally.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy